| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $3.78 | $6.32 | $1.59 | $1.12 | $1.15 | $1.95 | $0.92 | $0.51 |
| EPS (Diluted) | $3.78 | $6.30 | $1.58 | $1.12 | $1.14 | $1.95 | $0.92 | $0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.4B | $18.8B | $17.0B | $12.6B | $11.3B | $9.6B | $6.4B | $3.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | $0.2B | $1.0B | $0.2B | $0.5B | $0.3B |
| Total Liabilities | $17.2B | $16.6B | $15.3B | $11.2B | $10.1B | $8.8B | $5.7B | $3.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.3B | $2.2B | $1.7B | $1.5B | $1.2B | $0.8B | $0.7B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.3B | $-0.8B | $-0.4B | $1.0B | $-0.0B | $-0.9B | $-1.3B | $0.2B |
| Investing Cash Flow | $-0.2B | $-0.9B | $-3.3B | $-2.9B | $-0.5B | $-2.5B | $-1.0B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $1.6B | $4.0B | $1.1B | $1.4B | $3.1B | $2.4B | $0.3B |